Table 1.
Urinalysis | Cl | 100 mEq/L | ||
Protein | (-) | Ca | 8.0 mg/dL | |
Occult blood | (-) | IP | 3.2 mg/dL | |
Gravity | 1.019 | IgG | 864 mg/dL | |
IgG4 | 42 mg/dL | |||
Cell blood count | IgA | 198 mg/dL | ||
WBC | 4,000 /µL | IgM | 30 mg/dL | |
Segmented | 66.1% | IgE | 167 IU/mL | |
Stab | 0.0% | IgD | <6 mg/dL | |
Lymphocyte | 19.5% | CH50 | 77 U/mL | |
Basophil | 0.2% | C3 | 133 mg/dL | |
Eosinophil | 4.7% | C4 | 28.4 mg/dL | |
Monocyte | 9.5% | ACE | 8.4 IU/L | |
RBC | 393×104/µL | sIL-2R | 607 U/mL | |
Hemoglobin | 12.2 g/dL | |||
Platelet | 19.6×104/µL | Endocrinology | ||
TSH | 6.88 µIU/mL | |||
Blood chemistry | FT3 | 3.8 pg/mL | ||
Total protein | 5.4 g/dL | FT4 | 0.83 ng/dL | |
Albumin | 2.5 g/dL | Free testosterone | 1.3 pg/mL | |
AST | 22 IU/L | ACTH | <1.0 pg/mL | |
ALT | 11 IU/L | Cortisol | 0.4 µg/dL | |
ALP | 83 IU/L | DHEA-S | <50.0 µg/dL | |
LDH | 283 IU/L | PRA | 0.2 ng/mL/hr | |
CK | 77 U/L | PAC | 123 pg/mL | |
Fasting plasma glucose | 103 mg/dL | IGF-1 | 85 ng/mL | |
BUN | 12 mg/dL | iPTH | 41 pg/mL | |
Creatinine | 0.69 mg/dL | Urine free cortisol | not detected | |
Na | 133 mEq/L | Urine metanephrine | 0.12 mg/day | |
K | 4.5 mEq/L | Urine normetanephrine | 0.36 mg/day |
WBC: white blood cell, RBC: red blood cell, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, LDH: lactate dehydrogenase, CK: creatine kinase, BUN: blood urea nitrogen, IP: inorganic phosphorus, Ig: immunoglobulin, CH50: complement activities, C3: complement component 3, C4: complement component 4, ACE: angiotensin converting enzyme, sIL2Rc: soluble interleukin-2 receptor, TSH: thyroid stimulating hormone, FT3: free triiodothyronine, FT4 free thyroxine, ACTH: adrenocorticotropic hormone, DHEA-S: dehydroepiandrosterone sulfate, PRA: plasma renin activity, PAC: plasma aldosterone concentration, IGF-1: insulin-like growth factor 1, iPTH: intact parathyroid hormone